Literature DB >> 25051139

Sulforaphane and prostate cancer interception.

Maria H Traka1, Antonietta Melchini1, Richard F Mithen2.   

Abstract

Whereas much attention is focused on distinguishing newly diagnosed prostate cancers that will progress to become aggressive forms of the disease from those that will remain indolent, it is also appropriate to explore therapeutic and lifestyle interventions to reduce the risk of progression. Diets rich in broccoli have been associated with a reduction in risk of progression, which has been attributed to the compound sulforaphane. Although the mode of action of sulforaphane has been extensively studied in cell and animal models and a multiple of mechanisms that could underpin its protective effects have been proposed, recent evidence from human intervention studies suggests that sulforaphane is involved in a complex interplay between redox status and metabolism to result in a tissue environment that does not favour prostate cancer progression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25051139     DOI: 10.1016/j.drudis.2014.07.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  Glucosinolate and Desulfo-glucosinolate Metabolism by a Selection of Human Gut Bacteria.

Authors:  Vijitra Luang-In; Abdulhadi Ali Albaser; Carmen Nueno-Palop; Mark H Bennett; Arjan Narbad; John T Rossiter
Journal:  Curr Microbiol       Date:  2016-06-15       Impact factor: 2.188

2.  Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism.

Authors:  Allison J Greaney; Nolan K Maier; Stephen H Leppla; Mahtab Moayeri
Journal:  J Leukoc Biol       Date:  2015-08-12       Impact factor: 4.962

Review 3.  Hydrogen Sulfide Signaling Axis as a Target for Prostate Cancer Therapeutics.

Authors:  Mingzhe Liu; Lingyun Wu; Sabine Montaut; Guangdong Yang
Journal:  Prostate Cancer       Date:  2016-02-25

4.  Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials.

Authors:  Charlotte N Armah; Christos Derdemezis; Maria H Traka; Jack R Dainty; Joanne F Doleman; Shikha Saha; Wing Leung; John F Potter; Julie A Lovegrove; Richard F Mithen
Journal:  Mol Nutr Food Res       Date:  2015-04-07       Impact factor: 5.914

5.  Suppression of β-catenin Signaling Pathway in Human Prostate Cancer PC3 Cells by Delphinidin.

Authors:  Wooje Lee; Jung-Mi Yun
Journal:  J Cancer Prev       Date:  2016-06-30

6.  The Die Is Cast: Precision Electrophilic Modifications Contribute to Cellular Decision Making.

Authors:  Marcus J C Long; Yimon Aye
Journal:  Chem Res Toxicol       Date:  2016-10-02       Impact factor: 3.739

7.  Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association.

Authors:  Ya-Min Cheng; Ching-Chou Tsai; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

8.  Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.

Authors:  Namrata Khurana; Hogyoung Kim; Partha K Chandra; Sudha Talwar; Pankaj Sharma; Asim B Abdel-Mageed; Suresh C Sikka; Debasis Mondal
Journal:  Oncol Rep       Date:  2017-08-30       Impact factor: 3.906

Review 9.  Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer.

Authors:  Namrata Khurana; Suresh C Sikka
Journal:  Cancers (Basel)       Date:  2018-09-25       Impact factor: 6.639

10.  Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway.

Authors:  Ying Zhang; Qian Lu; Nan Li; Ming Xu; Tatsuo Miyamoto; Jing Liu
Journal:  NPJ Breast Cancer       Date:  2022-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.